Smith & Nephew plc
NYSE:SNNMedical - Devices
-$0.43 today
- Market cap
- $12.72B
- Beta
- 0.67
- P/E (TTM)
- 20.1
- EPS (TTM)
- $0.74
- Dividend yield
- 2.59%
Volume 1.22M
Average 1.10M
SNN Total Debt
Short-term and long-term borrowings combined.
Smith & Nephew plcNYSE: SNN
Total Debt · Q4 FY2025 · quarter ended Dec 2025
Total debt broadly unchanged from a year ago
Total debt stood at $3.33B at the end of Q4 FY2025, up 0.2% from a year earlier. Over 3 fiscal years it compounded at +5.0% a year.
Context
- Total debt amounted to 31.8% of total assets at the end of Q4 FY2025, down 0.3 pp from a year earlier.
- Total debt increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total debt keeps rising in the next quarterly balance sheet after a +0.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 3.33B USD
- Year-over-year change
- +0.2%
- 4-year CAGR
- -0.1%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.33B | +0.2% |
| FY2024 | 2024-12-31 | 3.32B | +7.7% |
| FY2023 | 2023-12-31 | 3.08B | +7.4% |
| FY2022 | 2022-12-31 | 2.87B | -14.0% |
| FY2021 | 2021-12-31 | 3.34B | — |
Total Debt vs competitors
How SNN compares with its peers on the latest reported figures
- SNN's Dec 2025 total debt of $3.33B is the 3rd highest of the 11 companies compared; the peer median is $731.96M.
- Its year-over-year change of +0.2% is the 5th highest of 11, against a peer median of -2.3%.
- Total debt amounts to 31.8% of total assets for SNN, versus a peer median of 32.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $14.94B | -12.8% | +6.5% | 31.2% | |
| Jun 2026 | $7.48B | -1.2% | +9.7% | 32.8% | |
| Dec 2025 | $3.33B | +0.2% | +5.0% | 31.8% | |
| Mar 2026 | $2.04B | +1.0% | +7.6% | 57.0% | |
| Apr 2026 | $1.41B | -3.3% | +60.3% | 36.8% | |
| Mar 2026 | $860.87M | -3.5% | -7.5% | 37.2% | |
| Mar 2026 | $603.06M | +3.7% | +16.1% | 75.4% | |
| Mar 2026 | $234.39M | +21.6% | +120.0% | 26.4% | |
| Jun 2026 | $111.19M | -8.2% | +170.3% | 2.0% | |
| Mar 2026 | $106.28M | +45.2% | +379.5% | 21.2% | |
| Mar 2026 | $15.44M | -55.0% | +18.9% | 19.8% | |
| Peer median (excluding SNN) | $731.96M | -2.3% | +17.5% | 32.0% | |
Competitors are the stored peer set for SNN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.29B | 350M | 302M | 619M | 557M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 971M | 1.03B | 1.06B | 1.21B | 1.43B |
| Inventory | 1.84B | 2.21B | 2.4B | 2.39B | 2.12B |
| Other Current Assets | 240M | 198M | 182M | 81M | (99M) |
| Total Current Assets | 4.42B | 3.86B | 4.03B | 4.42B | 4.1B |
| Property, Plant & Equipment (Net) | 1.51B | 1.46B | 1.47B | 1.42B | 1.64B |
| Goodwill | 2.99B | 3.03B | 2.99B | 3.03B | 3.11B |
| Intangible Assets | 1.4B | 1.24B | 1.11B | 1.03B | 882M |
| Long-term Investments | 380M | 58M | 24M | 16M | 151M |
| Tax Assets | 201M | 177M | 274M | 334M | 347M |
| Other Non-current Assets | 15M | 153M | 87M | 103M | 228M |
| Total Non-current Assets | 6.5B | 6.11B | 5.96B | 5.93B | 6.35B |
| Total Assets | 10.92B | 9.97B | 9.99B | 10.35B | 10.46B |
| Account Payables | 1.04B | 1.03B | 1.02B | 1.08B | 1.16B |
| Short-term Debt | 435M | 111M | 710M | 2M | 83M |
| Tax Payables | 222M | 214M | 218M | 232M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 597M | 526M | 261M | 126M | 85M |
| Total Current Liabilities | 2.13B | 1.72B | 2.27B | 1.53B | 1.6B |
| Long-term Debt | 2.71B | 2.57B | 2.18B | 3.12B | 3.03B |
| Deferred Tax Liabilities | 144M | 36M | 9M | 31M | 40M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 229M | 244M | 171M | 269M | 356M |
| Total Non-current Liabilities | 3.22B | 2.99B | 2.5B | 3.56B | 3.57B |
| Total Liabilities | 5.35B | 4.71B | 4.77B | 5.09B | 5.17B |
| Common Stock | 177M | 175M | 175M | 175M | 175M |
| Retained Earnings | 5.23B | 5.03B | 4.91B | 5.02B | 5.32B |
| Accumulated OCI | (328M) | (439M) | (385M) | 0 | 20M |
| Other Stockholders Equity | 0 | 0 | 0 | (497M) | (329M) |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 5.57B | 5.26B | 5.22B | 5.27B | 5.29B |
| Total Debt | 3.34B | 2.87B | 3.08B | 3.32B | 3.33B |
| Net Debt | 2.05B | 2.52B | 2.78B | 2.7B | 2.77B |
Smith & Nephew plc
NYSE:SNN
Intrinsic Alpha fair value
Locked
Current Price
$30.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.